The New York City Regional Center (“NYCRC”) is pleased to announce the first I-829 petition approvals issued to EB-5 investors participating in its Bronx Medical Office Campus project offering. I-829 petition approvals have now been issued in each of the NYCRC’s first nine offerings. To date, 1,147 I-829 approvals have been issued in NYCRC offerings resulting in over 3,000 individuals (EB-5 investors and family members) achieving permanent residency in the United States.
The issuance of the I-829 petition approval removes the conditional status and deems the EB-5 investor to be a lawful permanent resident of the United States. Permanent residence permits EB-5 investors to live and work anywhere in the United States, and be protected by the laws of the United States. An EB-5 investor’s spouse and children are also authorized to live, work and attend school anywhere in the United States.
“We congratulate our EB-5 investors on these recently issued I-829 petition approvals,” said Paul Levinsohn, Managing Principal of the NYCRC. “EB-5 investors have now received I-829 approvals in our first nine offerings.”
“Achieving over 1,100 I-829 petition approvals is a significant achievement for our company and our EB-5 investors and their families,” added George L. Olsen, Managing Principal of the NYCRC. “We extend our best wishes to them on their continued journey in the United States.”
The issuance of these new I-829 petition approvals represents the latest round of approval milestones for the NYCRC. Other examples include helping secure permanent residency in the United States for 5,305 EB-5 investors and family members and I-526 petition approvals for 2,393 EB-5 investors.